Ionis Pharmaceuticals Inc. buy JPMorgan Chase & Co.
Start price
08.10.25
/
50%
€59.76
Target price
08.10.26
€68.81
Performance (%)
18.21%
Price
19.02.26
€70.64
Summary
This prediction is currently active. The prediction currently has a performance of 18.21%. This prediction currently runs until 08.10.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ionis Pharmaceuticals Inc. | 2.525% | 2.525% |
| iShares Core DAX® | 1,43 % | 2,63 % |
| iShares Nasdaq 100 | 1,89 % | -0,46 % |
| iShares Nikkei 225® | -1,62 % | 11,10 % |
| iShares S&P 500 | 1,92 % | 1,16 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Ionis Pharmaceuticals Inc. diskutieren
Ionis Pharmaceuticals (NASDAQ:IONS) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $80.00 price target on the stock, up previously from $49.00.
Ratings data for IONS provided by MarketBeat